Table 2.
Responses to the Follow-Up Questionnaire: Patient Satisfaction Population
| n/N (%) (N = 6364) | |
|---|---|
| Patient filled in questionnaire 2 | |
| Yes | 6364/6364 (100.0) |
| Person who gave the insulin injection | |
| Self | 6188/6355 (97.4) |
| Parent | 11/6355 (0.2) |
| Spouse | 73/6355 (1.1) |
| Nurse/carer | 39/6355 (0.6) |
| Other | 44/6355 (0.7) |
| Missing (n) | 9 |
| Use of other insulin pen before SoloSTAR | |
| One other | 2463/6330 (38.9) |
| Two others | 1804/6330 (28.5) |
| Three or more | 442/6330 (7.0) |
| Never | 1621/6330 (25.6) |
| Missing (n) | 34 |
| Type of insulin currently used | |
| Insulin glargine only | 2036/6228 (32.7) |
| Insulin glulisine only | 39/6228 (0.6) |
| Insulin glargine and apidra | 2157/6228 (34.6) |
| Insulin glargine + one other insulin | 1870/6228 (30.0) |
| Insulin glargine + two other insulins | 26/6228 (0.4) |
| Insulin glargine + three other insulins | 15/6228 (0.2) |
| Insulin glulisine + one other insulin | 83/6228 (1.3) |
| Insulin glulisine + two other insulins | 1/6228 (0.0) |
| Insulin glulisin + three other insulins | 1/6228 (0.0) |
| Missing (n) | 136 |
| Number of injection devices currently used | |
| SolorSTAR only | 4110/6310 (65.1) |
| SolorSTAR + one other | 2180/6310 (34.5) |
| SolorSTAR + two others | 20/6310 (0.3) |
| Missing (n) | 54 |
| Start of SoloSTAR use the day patient | |
| received the supply | 5018/6333 (79.2) |
| Yes | 683/6333 (10.8) |
| No, 1 day later | 199/6333 (3.1) |
| No, 2 days later No, 3 days later | 113/6333 (1.8) |
| No, 4 days later | 318/6333 (5.0) |
| Yes/no, 2 days later | 1/6333 (0.0) |
| Yes/no 3 days later | 1/6333 (0.0) |
| Missing (n) | 31 |
| Patient was still using SoloSTAR | |
| Yes | 6245/6291 (99.3) |
| No, stopped 1–6 days ago | 22/6291 (0.3) |
| No, stopped 1–2 weeks ago | 10/6291 (0.2) |
| No, stopped 3–4 weeks ago | 9/6291 (0.1) |
| No, stopped 5–6 weeks ago | 5/6291 (0.1) |
| Missing (n) | 73 |
| Number of SoloSTAR pens used | |
| 1–7 pens | 4070/5941 (68.5) |
| 8–14 pens | 1362/5941 (22.9) |
| 15–21 pens | 352/5941 (5.9) |
| >21 pens | 157/5941 (2.6) |
| Missing (n) | 423 |
| Mean number of pens used (SD) | 7 (6.0) |
| Median number of pens used (Q1, Q3) | 5 (3, 9) |
| Disability or other restrictions | |
| None | 5151/5151 (100.0) |
| Missing (n) | 1213 |
| If patient has disability or other restrictions | |
| Poor eyesight not corrected by glasses/contact lenses | |
| Mild | 447/828 (54.0) |
| Moderate | 317/828 (38.3) |
| Severe | 64/828 (7.7) |
| Missing (n) | 482 |
| Manual dexterity problems | |
| Mild | 379/731 (51.8) |
| Moderate | 283/731 (38.7) |
| Severe | 69/731 (9.4) |
| Missing (n) | 482 |
| Other type of disability | |
| Mild | 153/322 (47.5) |
| Moderate | 126/322 (39.1) |
| Severe | 43/322 (13.4) |
| Missing (n) | 891 |
| Frequency of using a new needle | |
| Before every injection | 1488/6327 (23.5) |
| Every second day | 976/6327 (15.4) |
| Every third day | 1061/6327 (16.8) |
| Between 4–5 days | 1059/6327 (16.7) |
| Between 6–7 days | 822/6327 (13.0) |
| >7 days | 921/6327 (14.6) |
| Missing (n) | 37 |
| Frequency of safety test | |
| Before every injection | 2337/6283 (37.2) |
| Every second day | 686/6283 (10.9) |
| Once a week | 893/6283 (14.2) |
| With each new pen | 1843/6283 (29.3) |
| Only when there are air bubbles in the reservoir | 232/6283 (3.7) |
| Never | 292/6283 (4.6) |
| Missing (n) | 81 |
| Brand of needle used with SoloSTARa | |
| BD | 3224/6201 (52.0) |
| Novo Nordisk | 1713/6201 (27.6) |
| Ypsomed | 576/6201 (9.3) |
| Braun | 66/6201 (1.1) |
| Other | 484/6201 (7.8) |
| BD/Novo Nordisk | 77/6201 (1.2) |
| BD/Ypsomed | 18/6201 (0.3) |
| BD/Braun n/N | 2/6201 (0.0) |
| BD/other n/N | 9/6201 (0.1) |
| Novo Nordisk/Ypsomed | 3/6201 (0.0) |
| Novo Nordisk/other | 6/6201 (0.1) |
| Ypsomed/Braun | 2/6201 (0.0) |
| Braun/other | 2/6201 (0.0) |
| BD/Novo Nordisk/Ypsomed | 9/6201 (0.1) |
| BD/Novo Nordisk/Braun | 1/6201 (0.0) |
| BD/Novo Nordisk/other | 4/6201 (0.1) |
| BD/Ypsomed/B rau n | 3/6201 (0.0) |
| BD/Ypsomed/other | 1/6201 (0.0) |
| BD/Novo Nordisk/Ypsomed/Braun | 1/6201 (0.0) |
| Missing | 163 |
| Face-to-face training on the use of SoloSTAR | |
| Yes | 6101/6344 (96.2) |
| No | 243/6344 (3.8) |
| Missing (n) | 20 |
| Confidence in the use of the pen after the training | |
| Yes | 5905/6228 (94.8) |
| No | 323/6228 (5.2) |
| Missing | 136 |
| Number of days to be confident in the use of SoloSTAR | |
| 0 days | 767/6098 (12.6) |
| 1 day | 3515/6098 (57.6) |
| 2 days | 826/6098 (13.5) |
| 3 days | 436/6098 (7.1) |
| 4–8 days | 446/6098 (7.3) |
| >8 days | 108/6098 (1.8) |
| Missing | 266 |
| Mean number of days (SD) | 2 (2.3) |
| Median (Q1, Q3) | 1 (1,2) |
a
BD: Becton, Dickinson & Co.